WallStreetZenWallStreetZen

NASDAQ: PCSA
Processa Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for PCSA

Based on 2 analysts offering 12 month price targets for Processa Pharmaceuticals Inc.
Min Forecast
$4.00+86.05%
Avg Forecast
$6.00+179.07%
Max Forecast
$8.00+272.09%

Should I buy or sell PCSA stock?

Based on 2 analysts offering ratings for Processa Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PCSA stock forecasts and price targets.

PCSA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-25
lockedlocked$00.00+00.00%2024-03-06

1 of 1

PCSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PCSA$2.15$6.00+179.07%Buy
PTIX$1.39N/AN/A
IBIO$1.76N/AN/A
MYMD$2.84N/AN/A
SCPX$0.17N/AN/A

Processa Pharmaceuticals Stock Forecast FAQ

Is Processa Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PCSA) stock is to Buy PCSA stock.

Out of 2 analysts, 0 (0%) are recommending PCSA as a Strong Buy, 2 (100%) are recommending PCSA as a Buy, 0 (0%) are recommending PCSA as a Hold, 0 (0%) are recommending PCSA as a Sell, and 0 (0%) are recommending PCSA as a Strong Sell.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.

What is PCSA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PCSA price target, the average PCSA price target is $6.00, with the highest PCSA stock price forecast at $8.00 and the lowest PCSA stock price forecast at $4.00.

On average, Wall Street analysts predict that Processa Pharmaceuticals's share price could reach $6.00 by Apr 25, 2025. The average Processa Pharmaceuticals stock price prediction forecasts a potential upside of 179.07% from the current PCSA share price of $2.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.